Australia, July 7 -- Novo Nordisk A.S, owns the trademark (2641427) for 'Ayonzilo' till Feb. 25, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long-term weight loss maintenance.]
Type of Mark: Word
Date of Acceptance: April 27
Registration Advertised: July 6
For further details contact Novo Nordisk A.S .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2641427.
Disclaimer: Curated by HT Syndication....